Skip to content
Search

Latest Stories

PepsiCo withdraws lawsuits against Indian farmers

AMERICAN multinational giant, PepsiCo Inc said today (2) it will withdraw its lawsuits against a number of Indian potato farmers accused of infringing its patent.

After suing four farmers for cultivating the FC5 potato variety, grown exclusively for PepsiCo's popular Lay's potato chips, the snack food and drinks maker said last week it wanted to "amicably settle" the issue.


Other than filing the lawsuit against the four farmers in April, PepsiCo had also sued five other potato growers.

"After discussions with the government, the company has agreed to withdraw the cases against the farmers," a PepsiCo India spokesman said, adding that applied to all nine of them.

The decision comes after an influential group with close ties to prime minister Narendra Modi's ruling Bharatiya Janata Party accused PepsiCo of coercing the farmers.

PepsiCo maintains that it developed the FC5 variety, which has a lower moisture content required to make snacks such as potato chips, and registered the trait in 2016.

In April, the company filed the lawsuit in a court in Ahmedabad, the business hub of the western state of Gujarat, requesting the court to restrain the four farmers from growing the FC5 variety.

The company had also sought more than Rs 10 million each from the farmers.

The state government of Gujarat had assured the farmers that it would help them, Nitin Patel, deputy chief minister said last month.

The opposition Congress party had also criticised PepsiCo.

PepsiCo, which set up its first potato chips plant in India in 1989, supplies the FC5 potato variety to a group of farmers who in turn sell their produce to the company at a fixed price.

"The company remains deeply committed to the thousands of farmers we work with across the country and towards ensuring adoption of best farming practices," said the spokesman.

(Reuters)

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less